BioNTech SE has said it has started work to develop a vaccine against the Omicron variant of COVID-19. Omicron was first detected in South Africa. In a statement, BioNTech, which makes vaccines together with Pfizer (PFE.N), said the development of an adapted vaccine is part of the company’s standard procedure for new variants. RELATED STORY: …

The post BioNTech develops vaccine against COVID-19 Omicron variant appeared first on The Filipino Times.